These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33655428)

  • 1. Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes.
    Walker CH; Marchetti KA; Singhal U; Morgan TM
    World J Urol; 2022 Jan; 40(1):35-42. PubMed ID: 33655428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Narrative Overview of Active Surveillance for Clinically Localised Prostate Cancer.
    Bates AS; Kostakopoulos N; Ayers J; Jameson M; Todd J; Lukha R; Cymes W; Chasapi D; Brown N; Bhattacharya Y; Paterson C; Lam TBL
    Semin Oncol Nurs; 2020 Aug; 36(4):151045. PubMed ID: 32703714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance for prostate cancer: a systematic review of the literature.
    Dall'Era MA; Albertsen PC; Bangma C; Carroll PR; Carter HB; Cooperberg MR; Freedland SJ; Klotz LH; Parker C; Soloway MS
    Eur Urol; 2012 Dec; 62(6):976-83. PubMed ID: 22698574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence review of active surveillance in men with localized prostate cancer.
    Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
    Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
    Tosoian JJ; Mamawala M; Epstein JI; Landis P; Macura KJ; Simopoulos DN; Carter HB; Gorin MA
    Eur Urol; 2020 Jun; 77(6):675-682. PubMed ID: 31918957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance in prostate cancer: a critical review.
    Zargar H; Giannarini G; Loeb S; Dasgupta P; Murphy DG; Ficarra V
    Minerva Urol Nefrol; 2015 Sep; 67(3):247-61. PubMed ID: 26054412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk Prostate Cancer: Identification, Management, and Outcomes.
    Moschini M; Carroll PR; Eggener SE; Epstein JI; Graefen M; Montironi R; Parker C
    Eur Urol; 2017 Aug; 72(2):238-249. PubMed ID: 28318726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.
    van den Bergh RC; Ahmed HU; Bangma CH; Cooperberg MR; Villers A; Parker CC
    Eur Urol; 2014 Jun; 65(6):1023-31. PubMed ID: 24491309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades.
    Eifler JB; Alvarez J; Koyama T; Conwill RM; Ritch CR; Hoffman KE; Resnick MJ; Penson DF; Barocas DA;
    J Urol; 2017 Mar; 197(3 Pt 1):614-620. PubMed ID: 27984110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review.
    Gómez Rivas J; Carrion DM; Chandrasekar T; Álvarez-Maestro M; Enikeev D; Martínez-Piñeiro L; Barret E
    Actas Urol Esp (Engl Ed); 2021 Apr; 45(3):188-197. PubMed ID: 33189417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes.
    Komisarenko M; Martin LJ; Finelli A
    Transl Androl Urol; 2018 Apr; 7(2):243-255. PubMed ID: 29732283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance].
    López-Guerrero JA; Casanova-Salas I; Fernández-Serra A; Rubio L; Calatrava A; García-Flores M; García-Casado Z; Rubio-Briones J
    Arch Esp Urol; 2014 Jun; 67(5):462-72. PubMed ID: 24914846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement.
    Merriel SWD; Hetherington L; Seggie A; Castle JT; Cross W; Roobol MJ; Gnanapragasam V; Moore CM;
    BJU Int; 2019 Jul; 124(1):47-54. PubMed ID: 30742733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino S; Privitera S; Favilla V; Cantiello F; Manno S; Cicione A; Damiano R; Russo GI; Morgia G
    Anticancer Agents Med Chem; 2018; 18(7):958-963. PubMed ID: 29692262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer.
    Thurtle D; Barrett T; Thankappan-Nair V; Koo B; Warren A; Kastner C; Saeb-Parsy K; Kimberley-Duffell J; Gnanapragasam VJ
    BJU Int; 2018 Jul; 122(1):59-65. PubMed ID: 29438586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern Active Surveillance in Prostate Cancer: A Narrative Review.
    Pattenden TA; Samaranayke D; Morton A; Ong WL; Murphy DG; Pritchard E; Evans S; Millar J; Chalasani V; Rashid P; Winter M; Vela I; Pryor D; Mark S; Lawrentschuk N; Thangasamy IA
    Clin Genitourin Cancer; 2023 Feb; 21(1):115-123. PubMed ID: 36443163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Surveillance in Prostate Cancer: Current and Potentially Emerging Biomarkers for Patient Selection Criteria.
    Sotomayor PC; Aguilar JC; Mujica K; Zuñiga A; Godoy AS; Smith GJ; Mohler JL; Vitagliano G; San Francisco IF
    Urol Int; 2022; 106(12):1201-1213. PubMed ID: 36349773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.